+39 02 610346.1 - info@newron.com

Investors and Media

Investors and Media

Newron Pharmaceuticals is headquartered in Bresso, Italy and its shares are listed on SIX Swiss Exchange under the ticker symbol NWRN. Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, including our latest share price, key financial data and presentations and webcasts.

 

Newron news see all

Newron AGM Result and Clinical and Business Update

 

Newron updates on STARS study FDA interaction

 

Newron announces 2019 financial results and provides outlook for 2020

 

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

 

Newron Pharmaceuticals to Present at the 22nd Annual BIO CEO & Investor Conference in New York

Stock information

Download centre

Email alerts

 

 

 

 

 

Upcoming Eventssee all

Swiss Biotech Day 2020

September 15, 2020 - Basel, Switzerland 

H.C. Wainwright 22nd Annual Global Investment Conference

September 13-15, 2020 - New York, NY, USA 

Investora Zürich 2020

September 23-24, 2020 – Zürich-Stettbach, Switzerland